Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.97 USD | -3.93% | 0.00% | +51.16% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.16% | 670M | |
+48.72% | 56.95B | |
+39.98% | 40.26B | |
-7.09% | 39.32B | |
-4.42% | 28.37B | |
+12.37% | 26.45B | |
-18.01% | 19.41B | |
+29.16% | 12.54B | |
+25.94% | 12.21B | |
-0.17% | 12.15B |
- Stock Market
- Equities
- MLYS Stock
- News Mineralys Therapeutics, Inc.
- Mineralys Therapeutics Says Lorundrostat Showed 'Significant' Decline in Systolic Blood Pressure in Hypertension Phase 2 Trial